Related Experiment Video
Updated: Nov 8, 2025

Chronic Thromboembolic Pulmonary Hypertension and Assessment of Right Ventricular Function in the Piglet
Published on: November 4, 2015
Case of right ventricular and aortic thrombi in a patient with severe COVID-19
Henrietta Afari1, Leben Tefera2, Rachel P Rosovsky3
1Hospital Medicine Unit, Massachusetts General Hospital, Boston, Massachusetts, USA hafari@partners.org.
Insights
Severe COVID-19 can cause dangerous blood clots in both veins and arteries. This case report details a rare instance of combined venous and arterial thrombosis in a diabetic patient, emphasizing the need for further research.
Area of Science:
- Cardiology
- Hematology
- Infectious Diseases
Background:
- COVID-19 is increasingly linked to a prothrombotic state.
- The virus can lead to both venous and arterial thromboembolic complications, especially in severe cases.
Observation:
- A 61-year-old woman with diabetes, hypertension, and hyperlipidemia presented with cough and abdominal pain.
- Elevated D-dimer levels were detected, leading to imaging that revealed right ventricle and aortic thrombi.
Findings:
- The patient experienced rapid clinical deterioration.
- Treatment with tissue plasminogen activator resulted in significant clinical improvement.
- This case illustrates a rare co-occurrence of venous and arterial thrombosis in severe COVID-19.
Implications:
- Further research is required to understand the mechanisms of COVID-19 coagulopathy.
- The role of D-dimer in predicting and stratifying thrombosis risk in COVID-19 patients needs clarification.
- The efficacy of fibrinolytic therapy for COVID-19-associated thrombosis warrants investigation.
Abstract:
Emerging evidence suggests that novel COVID-19 is associated with increased prothrombotic state and risk of thromboembolic complications, particularly in severe disease. COVID-19 is known to predispose to both venous and arterial thrombotic disease. We describe a case of a 61-year-old woman with history of type II diabetes, hypertension and hyperlipidaemia who presented with dry cough and acute abdominal pain. She was found to have a significantly elevated D-dimer, prompting imaging that showed thrombi in her right ventricle and aorta. She had rapid clinical deterioration and eventually required tissue plasminogen activator with subsequent durable clinical improvement. This case highlights a rare co-occurrence of venous and arterial thrombi in a patient with severe COVID-19. Further studies are needed to clarify the molecular mechanism of COVID-19 coagulopathy, the utility of D-dimer to predict and stratify risk of thrombosis in COVID-19, and the use of fibrinolytic therapy in patients with COVID-19.
Related Concept Videos
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
Aneurysm II: Clinical Manifestations and Diagnostic Studies
Aortic Regurgitation III: Medical Management
Myocarditis III: Medical Management
Cardiac Catheterization II: Right Heart Catheterization
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

